ClinicalTrials.Veeva

Menu

Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Heterozygous Haemoglobinopathy

Treatments

Other: pregnancy outcome

Study type

Observational

Funder types

Other

Identifiers

NCT03837119
2018-00101 sp19Hoesli;

Details and patient eligibility

About

This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.

Enrollment

540 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women with or without heterozygous hemoglobinopathy

Exclusion criteria

  • refusal of study participation

Trial design

540 participants in 2 patient groups

Heterozygous Hemoglobinopathy
Description:
pregnancy outcome in women with heterozygous hemoglobinopathy
Treatment:
Other: pregnancy outcome
No Heterozygous Hemoglobinopathy
Description:
pregnancy outcome in women without heterozygous hemoglobinopathy
Treatment:
Other: pregnancy outcome

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems